1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067568, U10CA021115, ECOG-4697, SWOG-E4697, E4697, NCT00005034
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-97-C-0046, NCI-97-C-0019, NCI-T96-0046N, T96-0046, NCT00019214
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: Not specified Sponsor: NCI, Other Protocol IDs: CDR0000065424, UCCRC-9018, UCCRC-8381, NCI-G97-1162, NCT00002952
|
|
4.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: GENZ-ADVMEL-001-99, DFCI-00069, GENZ-2000-P-000380/1, NCT00010309
|
|
5.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: NCI-98-C-0023, NCI-T97-0089, T97-0089
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: Not specified Sponsor: NCI Protocol IDs: NCI-98-C-0040, NCI-T97-0092, T97-0092, NCT00019396
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: NCI-99-C-0092, NCI-T99-0033, T99-0033, NCT00019721
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: 990158, 99-C-0158, NCI-99-C-0158, NCI-T99-0078, T99-0078, NCT00019942, NCT00001832
|
|
9.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: NCI-99-C-0159, NCI-T99-0079, T99-0079, NCT00019994
|
|
10.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: LAC-USC-10M991, NCI-G00-1837, NCI-T99-0102, NCT00006113, T99-0102
|
|
11.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: E-1696, NCT00006385, E1696
|
|
12.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: NCI-01-C-0074, NCI-2910, 2910, NCT00020475
|
|
13.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: LAC-USC-10M011, LAC-USC-IRB-013030, NCI-5506, NCT00031733, 5506
|
|
14.
|
Phase: Phase II Type: Treatment Status: Closed Age: 16 and over Sponsor: NCI Protocol IDs: 030172, 03-C-0172, NCI-03-C-0172, NCI-6211, 6211, NCT00062218, NCT00059475
|
|
15.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UCCRC-11447A, NCI-1330, NCT00064168, 1330
|
|
16.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: CDR0000365467, P30CA076292, P30CA014089, MCC-15241, MDX010-16, NCI-6446, CA184-016, 6446, LAC-USC-10M036, NCT00084656
|
|
17.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: LAC-USC-10M038, LAC-USC-042011, LAC-USC-0A1033, NCI-6618, 6618, NCT00089063
|
|
18.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-06-C-0028, 7547, NCI-7547, NCI-P6574, NCT00303836
|
|
19.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-06-C-0041, 7542, NCI-7542, NCI-P6702, NCT00295958
|
|
20.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: LAC-USC-10M-03-1, 6262, NCI-6262, LAC-USC-033307, NCT00334776
|
|
21.
|
Phase: Phase I Type: Treatment Status: Completed Age: over 18 Sponsor: NCI Protocol IDs: NCI-95-C-0032D, NCI-T96-0026N, T96-0026
|
|
22.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-95-C-0071C, NCI-T94-0178N, T94-0178
|
|
23.
|
Phase: Phase I Type: Treatment Status: Completed Age: over 18 Sponsor: NCI Protocol IDs: NCI-95-C-0068C, NCI-T94-0137N, T94-0137
|
|
24.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-95-C-0079D, NCI-T94-0195N, T94-0195
|
|
25.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-95-C-0143B, NCI-T95-0039N, T95-0039
|